What podcasts say about Pascal Soria

Every statement, with the speaker, the exact quote and the moment it was said.

What Pascal Soria has said on podcasts

8 statements · 8 positive

on AstraZenecaPositiveJun 5, 2026· Mad Money w/ Jim Cramer
AstraZeneca will be the largest British company with a U.S. share in the United States.
“We are going to be the largest British company with a U.S. share in the United States.”
Listen at 13:11
Open the episode · Mad Money w/ Jim Cramer 6/5/26
on AstraZeneca New York listingPositiveJun 5, 2026· Mad Money w/ Jim Cramer
The New York listing enables U.S. shareholders to buy AstraZeneca shares directly.
“U.S. shareholders who are not comfortable or not able to buy an EDR can buy our shares.”
Listen at 13:32
Open the episode · Mad Money w/ Jim Cramer 6/5/26
on AstraZeneca Kendall Square research centerPositiveJun 5, 2026· Mad Money w/ Jim Cramer
AstraZeneca’s Kendall Square site will employ 3,000 pipeline scientists.
“where we will have 3,000 scientists working on our pipeline.”
Listen at 14:29
Open the episode · Mad Money w/ Jim Cramer 6/5/26
on AstraZeneca revenue targetPositiveJun 5, 2026· Mad Money w/ Jim Cramer
“we are on our way to getting there”
Listen at 15:06
Open the episode · Mad Money w/ Jim Cramer 6/5/26
on AstraZeneca lung-cancer treatmentsPositiveJun 5, 2026· Mad Money w/ Jim Cramer
AstraZeneca expects its oncology portfolio to defend its lung-cancer position.
“we think we have what it takes to defend our position in lung cancer treatment and continue improving the treatment of this condition.”
Listen at 16:59
Open the episode · Mad Money w/ Jim Cramer 6/5/26
on AstraZeneca oral GLP-1PositiveJun 5, 2026· Mad Money w/ Jim Cramer
AstraZeneca will present phase 2b oral GLP-1 data and advance it to phase 3.
“we will present data phase 2b, data with our oral GLP-1. And very exciting data. We're moving this product into phase 3.”
Listen at 18:07
Open the episode · Mad Money w/ Jim Cramer 6/5/26
on Artificial intelligence in drug developmentPositiveJun 5, 2026· Mad Money w/ Jim Cramer
AI can optimize drug molecules and remove potential side effects.
“AI helps you do this.”
Listen at 19:55
Open the episode · Mad Money w/ Jim Cramer 6/5/26
on PathosPositiveJun 5, 2026· Mad Money w/ Jim Cramer
AstraZeneca’s Pathos agent helps predict phase-three trial success.
“helps us predict the probability of success of a phase three trial.”
Listen at 20:20
Open the episode · Mad Money w/ Jim Cramer 6/5/26

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.